Search

Your search keyword '"Clayton Act"' showing total 729 results

Search Constraints

Start Over You searched for: Descriptor "Clayton Act" Remove constraint Descriptor: "Clayton Act"
729 results on '"Clayton Act"'

Search Results

101. Antitrust Analysis of Physician Mergers and Acquisitions under Section 7 of the Clayton Act

102. Meta/Within Merger Antitrust Opinion: Cutting Edge Tech, Vintage Precedent

104. DURBIN URGES DOJ, FTC TO INVESTIGATE INTERLOCKING DIRECTORATES IN THE LIFE SCIENCE INDUSTRY

105. Developments In US Antitrust Criminal Enforcement-2022 Year In Review

106. FTC Announces 2023 Thresholds Under HSR Act And Clayton Act New Filing Fee Schedule Implemented

107. Hart-Scott-Rodino Reporting Thresholds And Filing Fee Structure To Change Significantly

108. FTC Increases 2023 Thresholds For HSR Filings And Interlocking Directorates

109. FTC Announces Increased Hart-Scott-Rodino And Clayton Act Section 8 Interlocking Directorate Thresholds For 2023

110. FTC Announces 2023 Thresholds For Merger Control Filings Under HSR Act And Interlocking Directorates Under The Clayton Act

111. FTC ANNOUNCES 2023 UPDATE OF SIZE OF TRANSACTION THRESHOLDS FOR PREMERGER NOTIFICATION FILINGS AND INTERLOCKING DIRECTORATES

112. Private Equity & Healthcare: Antitrust Enforcement In 2023-PE Roll-Ups In The Cross Hairs

113. Federal Trade Commission Issues New Policy Statement Regarding The Scope Of 'Unfair Methods Of Competition' Under Section 5 Of The FTC Act

114. FAQ About The FTC's Controversial New 'Unfair Methods Of Competition' Policy

115. Antitrust expert says Ancora CEO cannot serve on Blucora's board

116. Mergers and Acquisitions in Digital Markets

117. The Facebook Antitrust Lawsuits and the Future of Merger Enforcement

118. Federal Trade Commission's Historic Attempt To Drive A Mack Truck Through The Sherman Act

119. FTC Issues New Policy Statement On 'Rigorous Enforcement' Against Unfair Methods Of Competition

120. FTC's New 'Unfair Methods Of Competition' Policy Statement Declares Protection For Competitors, Not Just Competition

121. FTC Policy Statement On The Scope Of Unfair Methods Of Competition - A Broad But Vague Warning

122. A Dose Of Steroids: Chair Khan's FTC Releases Expansive Policy Statement On Unfair Methods Of Competition

123. FTC Reinterprets FTC Act to Include Broad Powers Related to 'Interlocking Directorates' Under New Interpretation, Safe Harbors Might No Longer Apply and Board Observers Might Be Covered

124. Federal Trade Commission Issues Expansive New Policy Statement Regarding Enforcement Powers Under Section 5 Of The FTC Act November 11, 2022

126. Board Directors Beware: U.S. Antitrust Agencies Ramp Up Enforcement Of Interlocking Directorates

127. DOJ Reinvigorates Scrutiny Of Interlocking Directorates

128. DOJ Reinvigorates Scrutiny of Interlocking Directorates

129. DOJ Makes Good On Promise To Actively Prosecute Interlocking Directorships

130. DOJ Reinvigorates Crackdown On Interlocking Directorates

131. DOJ Requires Directors To Resign From Boards To Mitigate Antitrust Concerns

132. Hospital Mergers: The Future Of COPA Immunity

133. Clayton Act Questions For D&O Questionnaires

135. DOJ's First Large Scale Crackdown On Potentially Unlawful Interlocking Directorates Led To 7 Board Resignations Across 5 Tech Companies

136. Justice Department Goes On The Offensive Against Board Interlocks

137. DOJ Makes Good On Promise To Review Interlocking Directorates

138. U.S. Antitrust Authorities' Recent Scrutiny Of Interlocking Directorates Signals Escalation Of Enforcement Under Section 8 Of The Clayton Act

139. Breaking The Interlocking Chain: DOJ's Renewed Focus On Preventing Overlap Between Corporate Boards

140. DOJ Antitrust Targets Directors Serving On Boards Of Competing Companies

141. DIRECTORS RESIGN FROM THE BOARDS OF FIVE COMPANIES IN RESPONSE TO JUSTICE DEPARTMENT CONCERNS ABOUT POTENTIALLY ILLEGAL INTERLOCKING DIRECTORATES

142. New Kids On The Blockchain: Antitrust Trends In Web3.0 And FashionTech (Podcast)

143. Competition Litigation Laws And Regulations

144. Antitrust M&A Snapshot | Q2 2022

145. DOJ's Kanter: New Merger Guidelines To Address Enforcement's 'Disconnect' With Court Precedent And Market Realities

147. Altria Group/JUUL Labs: An Antitrust Violation For Antitrust Clearance Strategy And Transaction Non-Competes?

148. Is It Time For Antitrust Lawyers To Pay Attention To Interlocking Directorates And Section 8 Of The Clayton Act?

149. The customer is not always right: balancing worker and customer welfare in antitrust law.

150. Navigating through the fog of vertical merger law: a guide to counselling hospital-physician consolidation under the Clayton Act.

Catalog

Books, media, physical & digital resources